🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mario Sznol

Yale Cancer Center

ORCID: 0000-0002-4359-8749

Also affiliated with Yale University

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study”.

Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0328

N/A

2.1DataRank · unranked

61 citations

Omid Hamid, Asha Nayak-Kapoor, Solmaz Sahebjam, Mario Sznol, Agron Collaku +4 more

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005147

N/A

1.7DataRank · unranked

66 citations

Michael J. Pishvaian, Margaret K. Callahan, Amy Weise, Branimir I. Šikić, Osama E. Rahma +19 more

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

Nature Medicine(2022)10.1038/s41591-021-01623-z

N/A

0.864DataRank · unranked

316 citations

Aadel A. Chaudhuri, Aishwarya Nene, Antonietta Bacchiocchi, Noah Earland, Matthew D. Vesely +15 more

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

Molecular Cancer(2023)10.1186/s12943-023-01884-x

N/A

0.635DataRank · unranked

14 citations

Sarah A. Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi +18 more

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function

Frontiers in Oncology(2022)10.3389/fonc.2022.836859

N/A

0DataRank · unranked

77 citations

Sarah A. Weiss, Matthew Austin, Amit Mahajan, Katrina Etts, Lin Zhang +7 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma

Cellular and Molecular Life Sciences(2022)10.1007/s00018-022-04364-5

N/A

0DataRank · unranked

13 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Olivia K. Provance +8 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of distant metastasis initiation in melanoma

Research Square(2022)10.21203/rs.3.rs-1244262/v1

N/A

0DataRank · unranked

0 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Thuy Tran +7 more

Ablation of Histone Demethylase KDM5B in Melanoma Augments Anti-Tumor Immunity through Upregulation of Retroelements

Research Square(2020)10.21203/rs.3.rs-87705/v1

N/A

0DataRank · unranked

0 citations

Wesley L. Cai, Xiaoni Liu, Durga Thakral, Goran Micevic, Carmen J. Booth +10 more

Determinants of overall survival in patients with metastatic uveal melanoma

Cancer(2023)10.1002/cncr.34927

N/A

0DataRank · unranked

11 citations

Renelle Pointdujour‐Lim, Sofia Miguez, Yesung Lee, Bailey S.C.L. Jones, Christopher A. Barker +8 more

Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma

Ophthalmology(2023)10.1016/j.ophtha.2023.01.020

N/A

0DataRank · unranked

7 citations

R. Lee, Alison Chan, Patrick Demkowicz, Bailey S.C.L. Jones, Christopher P. Long +9 more

Data from C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas

(2023)10.1158/1078-0432.c.6517974

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Saadia A. Aziz, Patricia J. Conrad, John C. Schmitz, Mario Sznol +4 more

Data from A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1

(2023)10.1158/1078-0432.c.6530444

N/A

0DataRank · unranked

0 citations

Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia B. Jilaveanu +17 more

Interferon-stimulated neutrophils as a predictor of immunotherapy response

Cancer Cell(2024)10.1016/j.ccell.2023.12.005

N/A

0DataRank · unranked

153 citations

Tim J. Cooper, Prajakta Kalkar, Sagie Schif‐Zuck, Ruth Halaban, Antonella Bacchiocchi +16 more

Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction

EMBO Molecular Medicine(2024)10.1038/s44321-024-00115-0

N/A

0DataRank · unranked

10 citations

Tao Liu, Antonella Bacchiocchi, Mengxing Li, Wen Cheng, Tobias Wittkop +13 more

Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction

medRxiv(2024)10.1101/2024.01.13.24301070

N/A

0DataRank · unranked

1 citations

Tao Liu, Antonella Bacchiocchi, Mengxing Li, Wen Cheng, Tobias Wittkop +13 more